Biohaven Pharmaceutical Holding Company LtdMost RecentCompany & Industry OverviewsInsys Therapeutics: Recommendations and Market CapitalizationWall Street analysts estimate that INSY stock could decrease ~3% over the next 12 months. That show a 12-month target price of $9.60.
Company & Industry OverviewsInsys Therapeutics: Recommendations and Market CapitalizationWall Street analysts estimate that INSY stock could decrease ~3% over the next 12 months. That show a 12-month target price of $9.60.
